Moreover, serum exosomal lncRNA PCSK2-2:1 is also considered as a potential diagnostic biomarker for GC due to the fact that the downregulation of PCSK2-2:1 can predict the tumor size, tumor stage, and venous invasion [103]. The gene discussed is PCSK2; the disease is gastric cancer.